NO955356L - Behandling av hypotalamisk amenorre - Google Patents

Behandling av hypotalamisk amenorre

Info

Publication number
NO955356L
NO955356L NO955356A NO955356A NO955356L NO 955356 L NO955356 L NO 955356L NO 955356 A NO955356 A NO 955356A NO 955356 A NO955356 A NO 955356A NO 955356 L NO955356 L NO 955356L
Authority
NO
Norway
Prior art keywords
alkyl
hydrogen
treatment
hypothalamic
formula
Prior art date
Application number
NO955356A
Other languages
English (en)
Other versions
NO955356D0 (no
Inventor
Gertrude Virginia Upton
Albert Thomas Derivan
Richard Leslie Rudolph
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23502899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO955356(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO955356D0 publication Critical patent/NO955356D0/no
Publication of NO955356L publication Critical patent/NO955356L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Foreliggende oppfinnelse er basert på den oppdagelse at i hydroksycykloalkanfenetylaminforbindelser som har følgende i strukturformel: hvori A er en gruppe med formelen OR, J hvori den stiplede linje representerer eventuell umetning; R! er hydrogen eller alkyl; R2 er alkyl; R, er hydrogen, alkyl, formyl eller alkanoyl; R5 og R6 uavhengig er hydrogen, hydroksyl, alkyl, alkoksy, alkanoyloksy, cyano, nitro, alkylmerkapto, amino, alkylamino, dialkylamino, alkanamido, halogen, tri- fluormetyl, eller tatt til sammen, metylendioksy; R, er hydrogen eller alkyl; og n er O, l, 2, 3 eller 4; og deres farmasøytisk akseptablse salter er anvendelige for behandlng av hypotalamisk amenorré hos et ikke-deprimert hunn- pattedyr.
NO955356A 1995-01-30 1995-12-29 Behandling av hypotalamisk amenorre NO955356L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/380,903 US5506270A (en) 1995-01-30 1995-01-30 Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women

Publications (2)

Publication Number Publication Date
NO955356D0 NO955356D0 (no) 1995-12-29
NO955356L true NO955356L (no) 1996-07-31

Family

ID=23502899

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955356A NO955356L (no) 1995-01-30 1995-12-29 Behandling av hypotalamisk amenorre

Country Status (17)

Country Link
US (1) US5506270A (no)
EP (1) EP0723779A1 (no)
JP (1) JPH08231387A (no)
KR (1) KR960028906A (no)
CN (1) CN1137894A (no)
AR (1) AR001074A1 (no)
AU (1) AU703529B2 (no)
CA (1) CA2167999A1 (no)
CZ (1) CZ22996A3 (no)
FI (1) FI956339A (no)
HU (1) HUT75095A (no)
IL (1) IL116935A0 (no)
NO (1) NO955356L (no)
NZ (1) NZ280744A (no)
PE (1) PE13197A1 (no)
SK (1) SK11596A3 (no)
ZA (1) ZA9511038B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US20060068001A1 (en) * 1996-03-25 2006-03-30 Wyeth Extended release formulation
US6274171B1 (en) 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
US20030215507A1 (en) * 1996-03-25 2003-11-20 Wyeth Extended release formulation
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
CZ20013607A3 (cs) * 1999-04-06 2002-06-12 Sepracor Inc. Farmaceutický prostředek
US20020035158A1 (en) * 1999-06-15 2002-03-21 American Home Products Corporation Enantiomers of N-desmethyl venlafaxine
US20020022662A1 (en) * 1999-06-15 2002-02-21 American Home Products Corporation Enantiomers of O-desmethyl venlafaxine
US7291646B2 (en) * 1999-11-24 2007-11-06 Wyeth Ethers of O-desmethyl venlafaxine
US6348494B1 (en) 2000-11-21 2002-02-19 American Home Products Corporation Ethers of o-desmethyl venlafaxine
US6572890B2 (en) * 2000-01-13 2003-06-03 Osmotica Corp. Osmotic device containing venlafaxine and an anti-psychotic agent
FR2807753B1 (fr) * 2000-04-13 2002-06-07 Adir Nouveaux derives d'heterocycloalkylbenzocyclobutane et d'heteroarylbenzocyclobutane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP4220243B2 (ja) * 2001-02-12 2009-02-04 ワイス Ｏ−デスメチル−ベンラファキシンの新規コハク酸塩
UA77234C2 (en) * 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)
CA2467593A1 (en) * 2001-12-05 2003-06-19 Wyeth Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
AU2003219117A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Extended release venlafaxine formulations
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
US20070077301A1 (en) * 2002-12-23 2007-04-05 Meyer Glenn A Venlafaxine osmotic device formulation
EP1523979A1 (en) * 2003-10-13 2005-04-20 Wyeth Extended release pharmaceutical dosage form
EP1523981A1 (en) * 2003-10-13 2005-04-20 Wyeth Extended release formulations of venlafaxine
JP2009500420A (ja) * 2005-07-06 2009-01-08 セプラコア インコーポレーテッド エスゾピクロン及びｏ−デスメチルベンラファキシンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
AU2006322057A1 (en) * 2005-12-05 2007-06-14 Wyeth Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
KR100965527B1 (ko) * 2008-05-08 2010-06-23 제일약품주식회사 신규(4-(2-(디메틸아미노)-1-(1-하이드록시사이클로헥실)에틸)페녹시)포스페이트 또는 이의 약학적으로 허용가능한 염,이의 제조방법 및 이를 유효성분으로 함유하는 중추신경계질환 예방 및 치료용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110438A (en) * 1977-03-21 1978-08-29 American Home Products Corporation Method of treating depression
US4291028A (en) * 1977-12-30 1981-09-22 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
US4292315A (en) * 1977-12-30 1981-09-29 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4761501A (en) * 1983-10-26 1988-08-02 American Home Products Corporation Substituted phenylacetamides
US4611078A (en) * 1983-10-26 1986-09-09 American Home Products Corporation Substituted phenylacetonitriles
US4826844A (en) * 1987-09-30 1989-05-02 American Home Products Corporation Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence

Also Published As

Publication number Publication date
SK11596A3 (en) 1997-05-07
KR960028906A (ko) 1996-08-17
NO955356D0 (no) 1995-12-29
AU4075295A (en) 1996-08-08
FI956339A0 (fi) 1995-12-29
FI956339A (fi) 1996-07-31
AU703529B2 (en) 1999-03-25
CN1137894A (zh) 1996-12-18
JPH08231387A (ja) 1996-09-10
CZ22996A3 (en) 1996-09-11
ZA9511038B (en) 1997-06-30
PE13197A1 (es) 1997-04-22
HU9503922D0 (en) 1996-03-28
NZ280744A (en) 2000-11-24
AR001074A1 (es) 1997-09-24
IL116935A0 (en) 1996-05-14
EP0723779A1 (en) 1996-07-31
CA2167999A1 (en) 1996-07-31
US5506270A (en) 1996-04-09
HUT75095A (en) 1997-04-28

Similar Documents

Publication Publication Date Title
NO955356L (no) Behandling av hypotalamisk amenorre
NO20012977L (no) N-ureidoalkylpiperidiner som modulatorer av chemokinreseptoraktivitet
DK0960109T3 (da) Fremgangsmåde til fremstilling af tolterodin
TR199900897T2 (xx) Ornat�lm�� aminoalkanfosfonik asitler.
BR0112160A (pt) Agentes antiinflamatórios seletivos para glicocorticóides
DE69709938D1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
BR9907788A (pt) Agentes antiinflamatórios seletivos paraglicocorticóides
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
TR200000025T2 (tr) Azetidinilpropilpiperidin türevleri, ara bağlarıyla tacikinin antagonistleri olarak kullanımları.
BR0007864A (pt) Composto, e, uso de um composto
ID24228A (id) (+)norcisaprida yang berguna untuk gangguan tertular 5-ht3 dan 5-ht4
DK0613366T3 (da) 5,6-dihydroxyindoliner som additiver til hårfarvende præparater
CA2244777A1 (en) 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
DK0865498T3 (da) Fremgangsmåde til fremstilling af substituerede arylmælkesyreholdige cyclodepsipeptider med 24 ringatomer
HUP0300615A2 (hu) Sibutramint és orlistatot tartalmazó gyógyszerkészítmény
BR0213731A (pt) Compostos de silìcio
MX9700245A (es) Nuevo compuesto quimico, su preparacion y su empleo como medicamento.
NO983178L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasaytisk preparat for behandling eller profylakse av menopausesymptomer
TR199900644T2 (xx) 1,2,3,4-Tetrahidro-benzofuro $3,2-c] piridin t�revleri.
IS4367A (is) CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín
DE69619259T2 (de) Amidin- und isothioharnstoffderivate als inhibitoren der stickstoffoxid-synthase
ITPD920145A1 (it) Uso terapeutico della fosforil-l-serina-n-acil-sfingosina
ES2028871T3 (es) Un procedimiento para la preparacion de un glicosido de antraciclina. .
SE9603285D0 (sv) New compounds
WO2000023059A3 (en) Use of anticonvulsant derivatives for treating alcohol dependency

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application